Bisolvon 10 Mg/G Oral Powder
Revised December 2015
AN: 01170/2015
SUMMARY OF PRODUCT CHARACTERISTICS
1. Name of the Veterinary Medicinal Product
Bisolvon 10mg/g Oral Powder
2. Qualitative and Quantitative Composition
Each gram contains
Active substance
10 mg Bromhexine hydrochloride per gram
For a full list of excipients, see Section 6.1
3. Pharmaceutical Form
Oral powder.
White, crystalline powder
4. CLINICAL PARTICULARS
4.1 Target species
Cattle, pigs, dogs and cats.
4.2 Indications for use, specifying the target species
As an aid to the treatment of respiratory disease in cattle, pigs, dogs and cats where mucus is a complicating factor.
4.3 Contraindications
None known.
4.4 Special warnings for each target species
None known.
4.5 Special precautions for use
(i) Special precautions for use in animals
None known.
(ii) Special precautions to be taken by the person administering the veterinary medicinal product to animals
Avoid contact with skin and eyes. In case of accidental eye contact, flush the affected eye with copious amounts of clean running water. Wash hands and exposed skin after administering the product.
4.6 Adverse reactions (frequency and seriousness)
None known.
4.7 Use during pregnancy, lactation or lay
Not applicable.
4.8 Interaction with other medicinal products and other forms of interaction
May be used in conjunction with antibiotics and/or sulphonamides, bronchodilators etc.
Amounts to be administered and administration route
For oral administration in the feed or drinking water. Add to feed or drinking water immediately before administration.
Species |
Dose of Bromhexine Hydrochloride (mg /kg) |
Total Daily Dose in g of Powder |
Frequency |
Duration of treatment (days) |
Cattle |
0.5 |
5 g/100 kg |
Once daily |
5 |
Pigs |
0.2-0.5 |
2-5g/100 kg |
Once daily |
5 |
Dogs |
2.0 |
2g/10 kg |
Twice daily |
5 |
Cats |
1.0 |
0.5g/5 kg |
Once daily |
7 |
The 500 g and 1 kg pack contains a white measure, delivering approximately 5 g when filled level. The sachet pack contains blue measuring scoops delivering approximately 0.5 g when filled level, suitable for the small animal doses.
The following table illustrates the use of these measures, on a per scoop basis.
Species |
Bodyweight (kg) |
Dose of Bisolvon Powder (g) |
No of white (5 g) scoops |
No. of blue (0.5 g) scoops |
Calves Cattle |
100 400 |
5 20 |
1 4 |
|
Pigs |
100 |
2-5 |
½-1 |
|
Dogs |
5 15 |
0.5 1.5 |
|
1 3 |
Cats |
5 |
0.5 |
|
1 |
Overdose (Symptoms, Emergency Procedures, Antidotes)
No treatment is specified.
Withdrawal period(s)
Meat and offal:
Cattle : 2 days.
Pigs : zero days.
Not permitted for use in cows producing milk for human consumption.
5. PHARMACOLOGICAL PROPERTIES
ATCVet code : QR05CB02
Summary Presentation of the active ingredient:
Bisolvon is a mucolytic with two
main pharmacological actions. Firstly it stimulates an increase in
the secretion of fluid by the mucus glands of the respiratory
tract. Secondly it breaks down the network of acid glycoprotein
fibres found in mucoid sputum, which are mainly responsible for the
characteristic viscosity. Bisolvon has been shown to increase
mucociliary clearance in calves suffering from respiratory
disease.
When Bisolvon is administered simultaneously with oxytetracycline
in cattle and pigs, the levels of the antibiotic in the bronchial
mucus are increased by more than 40%. The clinical significance of
this action is uncertain.
6. PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Glucose monohydrate
6.2 Incompatibilities
None known.
6.3 Shelf life
Shelf life of the veterinary medicinal product as packaged for sale : 5 years
Shelf life after dilution or reconstitution according to directions: 24 hours
Shelf life after first opening the immediate packaging: 7 days
6.4 Special precautions for storage
Do not store above 25°C. Store in a dry place. If sachets are to be used over a period of a few days, they should be resealed as well as possible between doses. Discard any unused material after 7 days. Discard any remaining medicated feed or drinking water which is not consumed within 24 hours.
6.5 Nature and composition of immediate packaging
Polyethylene/paper/aluminium foil laminate sachets (heat sealed) containing 5 g powder packed in boxes of 40 sachets with 0.5 g blue polystyrene measuring spoons.
100 g white high density polyethylene tub closed with white high density polyethylene screw-fit cap.
500 g white high density polyethylene tub closed with white high density polyethylene insert with polypropylene screw-fit cap.
1000 g white high density polyethylene container closed with white low density polyethylene push-fit cap.
The above three pack sizes come with a clear polystyrene spoon delivery approx 5g of powder.
Not all pack sizes may be marketed.
6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products
Any unused veterinary medicinal product or waste material derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
7. MARKETING AUTHORISATION HOLDER
Boehringer Ingelheim Ltd
Ellesfield Avenue
Bracknell
Berkshire
RG12 8YS
8. MARKETING AUTHORISATION NUMBER
Vm 00015/4072
9. DATE OF FIRST AUTHORISATION
8 April 2004
10. DATE OF REVISION OF THE TEXT
December 2015
09 December 2015
Page 4 of 4